Royal Biologics Partners with Vilex for Lower Extremities

Royal Biologics ALC Therapies

Royal Biologics entered into a distribution agreement whereby Vilex will market and distribute Royal Biologics' portfolio of Autologous and Live Cellular therapies for lower extremity orthopedic procedures.

Royal's product portfolio focuses on fully utilizing the potential of the patient's own cells to maximize efficacy in bone graft and wound...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0